» Articles » PMID: 32143838

NK Cells Prevent T Cell Lymphoma Development in T Cell Receptor-transgenic Mice

Overview
Journal Cell Immunol
Publisher Elsevier
Date 2020 Mar 8
PMID 32143838
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Mice that express a single transgenic T cell receptor have a low incidence of T cell lymphoma development. We investigated whether this tumor development is restricted by surveillance mechanisms that are exerted by IL-15-dependent cells. Lymphoma incidence was increased to between 30 and 60% when TCR transgenes were expressed in IL-15-deficient mice. Mice in which NK cells had been depleted genetically or with neutralizing antibodies allowed lymphoma growth while the absence of CD8 T cells was without consequence. Half of the emerged T cell lymphomas carried Notch1 mutations. The distinct phenotype of the lymphomas involved expression of PD1, CD30, CD24, the stress receptor ligand Mult1 and MHC class I down-regulation. NK cells were able to directly lyse lymphoma cells, and neutralizations of Mult1 and class I expression prevented NK cell degranulation. Together these data support an involvement of NK cells in tumor surveillance of nascent T cell lymphomas.

Citing Articles

High-multiplex single-cell imaging analysis reveals tumor immune contexture associated with clinical outcomes after CAR T cell therapy.

Jin J, Lin L, Meng J, Jiang L, Zhang M, Fang Y Mol Ther. 2024; 32(5):1252-1265.

PMID: 38504519 PMC: 11081919. DOI: 10.1016/j.ymthe.2024.03.023.


Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphomas in Mice.

Dubois S, Waldmann T, Muller J J Immunol. 2021; 207(4):1194-1199.

PMID: 34330751 PMC: 8355202. DOI: 10.4049/jimmunol.2001123.


Engagement of lymphoma T cell receptors causes accelerated growth and the secretion of an NK cell-inhibitory factor.

Dubois S, Waldmann T, Muller J Cell Immunol. 2020; 357:104213.

PMID: 32977157 PMC: 7554099. DOI: 10.1016/j.cellimm.2020.104213.

References
1.
Utz U, Banks D, Jacobson S, Biddison W . Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J Virol. 1996; 70(2):843-51. PMC: 189887. DOI: 10.1128/JVI.70.2.843-851.1996. View

2.
Wang W, Erbe A, Hank J, Morris Z, Sondel P . NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy. Front Immunol. 2015; 6:368. PMC: 4515552. DOI: 10.3389/fimmu.2015.00368. View

3.
Orange J . Natural killer cell deficiency. J Allergy Clin Immunol. 2013; 132(3):515-525. PMC: 3917661. DOI: 10.1016/j.jaci.2013.07.020. View

4.
Ritter J, Zimmermann K, Johrens K, Mende S, Seegebarth A, Siegmund B . T-cell repertoires in refractory coeliac disease. Gut. 2017; 67(4):644-653. PMC: 5868243. DOI: 10.1136/gutjnl-2016-311816. View

5.
Newrzela S, Al-Ghaili N, Heinrich T, Petkova M, Hartmann S, Rengstl B . T-cell receptor diversity prevents T-cell lymphoma development. Leukemia. 2012; 26(12):2499-507. DOI: 10.1038/leu.2012.142. View